<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td valign="top"> Study Population</td>
<td align="center" valign="top"> Regimens</td>
<td align="center" colspan="3" valign="top"> Relative Bioavailability</td>
</tr>
<tr>
<td valign="top"> </td>
<td valign="top"> Divalproex sodium extended-release tablets vs. Divalproex sodium delayed-release tablets</td>
<td valign="top"> AUC<sub>24</sub>
</td>
<td valign="top"> C<sub>max</sub>
</td>
<td valign="top"> C<sub>min</sub>
</td>
</tr>
<tr>
<td valign="top"> Healthy Volunteers (N=35)</td>
<td valign="top"> 1000 &amp; 1500 mg Divalproex sodium extended-release tablets vs.875 &amp; 1250 mg Divalproex sodium delayed-release tablets</td>
<td valign="top"> 1.059</td>
<td valign="top"> 0.882</td>
<td valign="top"> 1.173</td>
</tr>
<tr>
<td valign="top"> Patients with epilepsy on concomitant enzyme-inducing antiepilepsy drugs <br/>(N = 64) </td>
<td valign="top"> 1000 to 5000 mg Divalproex sodium extended-release tablets vs.875 to 4250 mg Divalproex sodium delayed-release tablets</td>
<td valign="top"> 1.008</td>
<td valign="top"> 0.899</td>
<td valign="top"> 1.022</td>
</tr>
</tbody>
</table>